name: Lactate Dehydrogenase [Enzymatic Activity/Volume] in Pleural Fluid


name: Lactate Dehydrogenase [Enzymatic Activity/Volume] in Pleural Fluid by Pyruvate To Lactate Reaction


name: Lactate Dehydrogenase [Enzymatic Activity/Volume] in Red Blood Cells


name: Lactate Dehydrogenase [Enzymatic Activity/Volume] in Semen


name: Lactate Dehydrogenase [Enzymatic Activity/Volume] in Serum or Plasma


name: Gastrin [Moles/Volume] in Serum or Plasma


name: Chromogranin A [Units/Volume] in Serum or Plasma by Immunoassay


name: Beta-2-Microglobulin [Presence] in Serum


name: FLT3 Gene Targeted Mutation Analysis in Blood or Tissue by Molecular Genetics Method


name: FLT3 Gene Targeted Mutation Analysis in Bone Marrow by Molecular Genetics Method


name: CHIC2 Gene 4q12 Deletion in Blood or Tissue by FISH


name: Chromosome 17 Copy Number/Nucleus in Tissue by FISH


name: Beta-2-Microglobulin [Moles/Volume] in Serum or Plasma


name: Beta-2-Microglobulin [Mass/Volume] in Peritoneal Dialysis Fluid


name: Encounter for Carrier of carbapenem-sensitive Acinetobacter baumannii


name: carrier of carbapenem-sensitive Acinetobacter baumannii


name: Encounter for Carrier of Enterobacterales


name: Encounter for Carrier of other Enterobacterales


name: Encounter for Basic services unavailable in physical environment


name: basic services unavailable in physical environment


name: Encounter for Non-relative guardian-child conflict


name: Gastrin [Mass/Volume] in Serum or Plasma


name: Lactate Dehydrogenase [Enzymatic Activity/Volume] in Urine


name: Chromogranin A [Mass/Volume] in Serum or Plasma


name: reproductive endocrinology and infertility surgical operation note


name: {126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet [Orenitram]) / 210 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet [Orenitram]) } Pack [Orenitram Month 2 Titration Kit]


name: {126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet [Orenitram]) / 42 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet [Orenitram]) } Pack [Orenitram Month 1 Titration Kit]


name: {126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet [Orenitram]) / 42 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet [Orenitram]) / 84 (12 HR treprostinil 1 MG Extended Release Oral Tablet [Orenitram]) } Pack [Orenitram Month 3 Titration Kit]


name: psychiatry telehealth admission evaluation note


name: community health care history and physical note


name: clinical cardiac electrophysiology history and physical note


name: undersea and hyperbaric medicine history and physical note


name: Somatotropin & glucose post glucose stimulation panel


name: Somatotropin & glucose post glucose stimulation panel:-:Pt:Ser/Plas:-


name: Human papilloma virus cytology and high-risk genotypes, Thin prep


name: Human papilloma virus cytology and high-risk genotypes panel:-:Pt:Cvx:-


name: Neonatal infant pain scale panel (NIPS):-:Pt:^Patient:-:NIPS


name: Glucose and somatotropin post glucagon stimulation panel


name: Glucose and somatotropin post glucagon stimulation panel:-:Pt:Ser/Plas:-


name: {9 (insulin, regular, human 12 UNT Inhalation Powder [Afrezza]) / 9 (insulin, regular, human 4 UNT Inhalation Powder [Afrezza]) / 9 (insulin, regular, human 8 UNT Inhalation Powder [Afrezza]) } Pack [Afrezza Sample Pack - 9 (4 UNT), 9 (8 UNT), 9 (12 UNT)]


name: {68 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 67.5 - 68.4 KG]


name: {66 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 65.5 - 66.4 KG]


name: {65 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 64.5 - 65.4 KG]


name: {64 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 63.5 - 64.4 KG]


name: CD33 Cells/100 Cells in Cerebral Spinal Fluid


name: Isocitrate Dehydrogenase [Enzymatic Activity/Volume] in Serum or Plasma


name: JAG1 Gene Deletion in Blood or Tissue by FISH


name: MALT1 18q21 Gene Rearrangements in Blood or Tissue by FISH


name: reproductive endocrinology and infertility history and physical note


name: FHIR resource patient medical record:Find:Pt:{Setting}:Doc


name: Progesterone Receptor [Interpretation] in Tissue


name: Lactate Dehydrogenase [Presence] in Urine


name: Decreased delta-aminolevulinate dehydratase activity


name: Subtelomere Analysis [Identifier] in Blood or Tissue by FISH Nominal


name: Beta-2-Microglobulin [Moles/Time] in 24 Hour Urine


name: {32 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 31.5 - 32.4 KG]


name: {23 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 22.5 - 23.4 KG]


name: {31 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 30.5 - 31.4 KG]


name: {36 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 35.5 - 36.4 KG]


name: {49 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 48.5 - 49.4 KG]


name: {58 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 57.5 - 58.4 KG]


name: {15 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 14.5 - 15.4 KG]


name: Epidermal Growth Factor Receptor [Moles/Mass] in Tissue


name: ERBB2 Gene Duplication [Presence] in Breast Cancer Specimen by FISH


name: ERBB2 Gene Duplication [Presence] in Tissue by FISH


name: Estrogen Receptor [Moles/Mass] in Tissue


name: MDM2 Gene Copy Number/Nucleus in Tissue by FISH


name: MET Gene Copy Number/Chromosome 7 Copy Number in Blood or Tissue by FISH


name: Progesterone Receptor Fluorescence Intensity [Type] in Breast Cancer Specimen by Immune Stain


name: Progesterone Receptor [Moles/Mass] in Tissue


name: PTEN Gene [Presence] in Cancer Specimen by FISH


name: Chromosome 19 Polysomy [Presence] in Tissue by FISH


name: Chromosome 12 Copy Number/Nucleus in Tissue by FISH


name: FOXO1 Gene Rearrangements in Tissue by FISH


name: Chromosome 1q and 9 and 11 and 15 Aneuploidy and 13q Deletion in Bone Marrow by FISH


name: Chromosome 9 and 11 and 15 Aneuploidy in Bone Marrow by FISH


name: Encounter for Carrier of Acinetobacter baumannii


name: Encounter for Unable to obtain adequate childcare due to limited financial resources


name: Encounter for Caregiver's noncompliance with patient's other medical treatment and regimen due to financial hardship


name: caregiver's noncompliance with patient's other medical treatment and regimen due to financial hardship


name: child and adolescent psychology history and physical note


name: chiropractic medicine history and physical note


name: MYC Gene Rearrangements [Interpretation] in Blood or Tissue by FISH Narrative


name: MYC Gene Rearrangements [Presence] in Blood or Tissue by FISH


name: RARA Gene Rearrangements [Presence] in Blood or Tissue by FISH


name: International Society of Paediatric Oncology Malignant Mesenchymal Tumour Committee


name: Beta-2-Microglobulin [Mass/Volume] in 24 Hour Urine


name: Chromosome 12 Aneuploidy in Amniotic Fluid or Chorionic Villus Sample by FISH Nominal


name: Beta-2-Microglobulin [Mass/Volume] in Pleural Fluid


name: medical aid in dying history and physical note


name: integrative medicine history and physical note


name: Cortisol, glucose and somatotropin post glucagon stimulation panel


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 9 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 14.1 - 14.5 kg]


name: {13 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 19.1 - 19.5 kg]


name: {10 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 14.6 - 15.0 kg]


name: Cortisol, glucose and somatotropin post glucagon stimulation panel:-:Pt:Ser/Plas:-


name: Chromogranin A [Mass/Volume] in Body Fluid


name: Chromogranin A [Moles/Volume] in Serum or Plasma


name: Chromogranin A [Units/Volume] in Pleural Fluid


name: Chromosome 1 Polysomy [Presence] in Tissue by FISH


name: Chromosome 12 Trisomy and Chromosome Region 11q22.3 and 13q14 and 17p13.1 Deletion in Blood or Tissue by FISH


name: Chromosome 18 Aneuploidy in Amniotic Fluid or Chorionic Villus Sample by FISH Nominal


name: FGFR1 Gene Rearrangements [Interpretation] in Blood or Tissue by FISH Narrative


name: FGFR1 Gene Rearrangements [Presence] in Blood or Tissue by FISH


name: Microdeletion Syndromes in Specimen by FISH Nominal


name: Microdeletion Syndromes [Identifier] in Blood or Tissue by FISH Nominal


name: Microsatellite Instability [Identifier] in Tissue by Molecular Genetics Method Nominal


name: Microsatellite Instability [Interpretation] in Cancer Specimen Qualitative


name: B-cell acute lymphoblastic leukemia:Find:Pt:Bld/Tiss:Doc:FISH


name: B-cell acute lymphocytic leukemia:Find:Pt:Bld/Tiss:Doc:FISH


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 10 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 15.6 - 16.0 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 8 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 13.6 - 14.0 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 9 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 15.1 - 15.5 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 12 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 19.6 - 20.0 kg]


name: {12 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 17.6 - 18.0 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 11 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 18.1 - 18.5 kg]


name: {11 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 16.1 - 16.5 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 12 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 18.6 - 19.0 kg]


name: {14 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 20.6 - 21.0 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 11 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 17.1 - 17.5 kg]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 10 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 16.6 - 17.0 kg]


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) / 13 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection [Zolgensma]) } Pack [Zolgensma Kit 20.1 - 20.5 kg]


name: caregiver's noncompliance with patient's renal dialysis due to financial hardship


name: Encounter for Caregiver's noncompliance with patient's renal dialysis due to financial hardship


name: caregiver's noncompliance with patient's renal dialysis for other reason


name: Encounter for Caregiver's noncompliance with patient's renal dialysis for other reason


name: carrier of carbapenem-resistant Acinetobacter baumannii


name: Encounter for Carrier of carbapenem-resistant Enterobacterales


name: carrier of carbapenem-resistant Enterobacterales


name: Encounter for Child in custody of non-parental relative


name: child in custody of non-parental relative


name: Encounter for Child in custody of non-relative guardian


name: child in custody of non-relative guardian


name: Progestin-containing Intrauterine System [EPC]


name: Interleukin-36 Receptor Antagonist [EPC]


name: Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]


name: Histamine-3 Receptor Antagonist/Inverse Agonist [EPC]


name: Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]


name: Aminolevulinate Synthase 1-directed RNA Interaction [EPC]


name: Survival of Motor Neuron 2 Splicing Modifier [EPC]


name: drainage of right frontal sinus (treatment)


name: active-assisted ext rot 0 deg abduct both shoulders deteriorate by (___ deg.)


name: kinesiotherapy history and physical note


name: ALK Gene Rearrangements [Presence] in Blood or Tissue by FISH


name: Anchored Multiplex Polymerase Chain Reaction


name: Beta-2-Microglobulin [Mass/Time] in 24 Hour Urine


name: Beta-2-Microglobulin [Mass/Volume] in Dialysis Fluid


name: Chromosome 2 Copy Number/Nucleus in Tissue by FISH


name: Chromosome 21 Aneuploidy [Presence] in Amniotic Fluid or Chorionic Villus Sample by FISH


name: Chromosome 3 and 7 and 17 Aneuploidy and Chromosome Region 9p21 Deletion in Urine by FISH


name: Chromosome 8 Copy Number/Nucleus in Blood or Tissue by FISH


name: Chromosome Painting Analysis in Blood or Tissue by FISH


name: Chromosome Region 13q14 Deletion in Bone Marrow by FISH


name: Chromosome Region 17p11.2 Deletion in Amniotic Fluid or Chorionic Villus Sample by FISH


name: Chromosome Region 17p13.1 Deletion in Blood or Tissue by FISH


name: Chromosome Region 17p13.3 Deletion in Amniotic Fluid or Chorionic Villus Sample by FISH


name: FLT3 Gene Internal Tandem Duplication [Presence] in Blood or Tissue by Molecular Genetics Method


name: FLT3 Gene Internal Tandem Duplication [Presence] in Bone Marrow by Molecular Genetics Method


name: Cancer staging after tumor recurrence:Find:Pt:Cancer.XXX:Nom


name: {3 (0.8 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [Hyrimoz]) } Pack [Hyrimoz Pediatric Crohn's Starter Kit Patient Weight > 40 KG]


name: Cyltezo Pen 40 MG/0.8 ML Auto-Injector includes 4-count & 6-count Starter Packs


name: Encounter for Difficulty understanding health related information


name: difficulty understanding health-related information (finding)


name: Encounter for Group home staff-child conflict


name: Beta-2-Microglobulin [Moles/Volume] in 24 Hour Urine


name: Beta-2-Microglobulin [Moles/Volume] in Body Fluid


name: Beta-2-Microglobulin [Moles/Volume] in Urine


name: Beta-2-Microglobulin [Presence] in Cerebral Spinal Fluid


name: Beta-2-Microglobulin [Presence] in Urine


name: Beta-2-Microglobulin [Units/Volume] in Urine by Immunoassay


name: Beta-2-Microglobulin/Creatinine [Mass Ratio] in 24 Hour Urine


name: Beta-2-Microglobulin/Creatinine [Molar Ratio] in Urine


name: Beta-2-Microglobulin/Creatinine [Ratio] in 24 Hour Urine


name: Chromosome Region 17p13.3 Deletion in Blood or Tissue by FISH


name: Chromosome Region 1p Subtelomere and 1p36 Deletion and 1q25 Rearrangement in Blood or Tissue by FISH


name: Chromosome Region 1p36 Deletion in Blood or Tissue by FISH


name: Chromosome Region 7q11.23 Deletion in Amniotic Fluid or Chorionic Villus Sample by FISH


name: Chromosome X and Y Aneuploidy in Blood or Tissue by FISH


name: The Latin American Group of Paediatric Oncology


name: Lactate Dehydrogenase [Enzymatic Activity/Volume] in Serum or Plasma by Pyruvate To Lactate Reaction


name: Lactate Dehydrogenase [Enzymatic Activity/Volume] in Specimen


name: Lactate Dehydrogenase [Enzymatic Activity/Volume] in Synovial Fluid by Lactate To Pyruvate Reaction


name: Lactate Dehydrogenase [Enzymatic Activity/Volume] in Synovial Fluid by Pyruvate To Lactate Reaction


name: MYB Gene Deletion [Presence] in Blood or Tissue by FISH


name: MYCN Gene Copy Number/Chromosome 2 Copy Number in Tissue by FISH


name: Encounter for Inadequate housing environmental temperature


name: inadequate housing environmental temperature


name: Encounter for Inadequate housing utilities


name: MYCN Gene Amplification in Blood or Tissue by FISH


name: MYCN Gene Copy Number/Nucleus in Tissue by FISH


name: {112 (treprostinil 0.016 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 16-48-64 MCG Maintenance Pack]


name: {112 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 48-64 MCG Maintenance Pack]


name: {112 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) / 112 (treprostinil 0.064 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 32-64 MCG Maintenance Pack]


name: Deprecated SARS-CoV-2 (COVID-19) RNA in Respiratory specimen by NAA with probe detection


name: Deprecated SARS-CoV-2 (COVID-19) in Respiratory specimen by NAA with probe detection


name: Clostridium tetani toxoid and corynebacterium diphtheriae Antibody panel


name: Glucose, somatotropin and cortisol post insulin administration


name: Glucose, somatotropin and cortisol post insulin administration:-:Pt:Ser/Plas:-


name: Deprecated Candida albicans DNA [Presence] in Specimen by NAA with probe detection


name: Deprecated Candida parapsilosis DNA [Presence] in Specimen by NAA with probe detection


name: Chlamydia trachomatis rRNA & Neisseria gonorrhoeae rRNA & Trichomonas vaginalis RNA & Candida sp RNA panel


name: Encounter for Non-parental relative or guardian-child conflict


name: non-parental relative or guardian-child conflict


name: Encounter for Problems related to health literacy


name: {20 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 19.5 - 20.4 KG]


name: {21 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 20.5 - 21.4 KG]


name: {22 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 21.5 - 22.4 KG]


name: {25 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 24.5 - 25.4 KG]


name: {40 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 39.5 - 40.4 KG]


name: {47 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 46.5 - 47.4 KG]


name: {51 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 50.5 - 51.4 KG]


name: {55 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 54.5 - 55.4 KG]


name: {59 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 58.5 - 59.4 KG]


name: {62 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 61.5 - 62.4 KG]


name: {28 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 27.5 - 28.4 KG]


name: {33 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 32.5 - 33.4 KG]


name: {41 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 40.5 - 41.4 KG]


name: {46 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 45.5 - 46.4 KG]


name: {60 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit 59.5 - 60.4 KG]


name: {2 (0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector [Hyrimoz]) / 1 (0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector [Hyrimoz]) } Pack [Hyrimoz Plaque Psoriasis Starter Kit]


name: METHOCARBAMOL 90 mg in 100 NOT APPLICABLE POWDER


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [HEB SPF 50 Pomegranate Continuous]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL STICK [Wegmans Kids Sunscreen Stick SPF 50]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [HEB SPF 50 Birthday Cake Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [HEB Shimmer Sunscreen SPF 50]


name: Avobenzone 30 mg in 1 mL / Ensulizole 30 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 80.7 mg in 1 mL TOPICAL CREAM [AHAVA MultiVitamin Day SPF30]


name: HOMOSALATE 10 g in 100 mL / OCTINOXATE 7.5 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL LIQUID [DR. BARBARA STURM MOLECULAR COSMETICS SPF 50 sunscreen]


name: OCTOCRYLENE 5 g in 100 g / AVOBENZONE 3 g in 100 g / HOMOSALATE 7.5 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL LOTION [CoreTex Sun X SPF 30 Multipack New]


name: TITANIUM DIOXIDE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL CREAM [BB OSKIN Broad Spectrum SPF-30]


name: ZINC OXIDE 200 mg in 1 g TOPICAL STICK [HEB SPF 50 Kids Blue Mineral Sunscreen Stick Berry Scented]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [HEB SPF 50 Mineral Sunscreen Stick]


name: ZINC OXIDE 5 g in 30 mL / TITANIUM DIOXIDE 5 g in 30 mL TOPICAL CREAM [YOUR NAME MINERAL SHEERTINT BROAD SPECTRUM SPF 20- HONEY GLOW]


name: MANGO 500 mg in 2 g / BANANA 500 mg in 2 g / WHITE MULBERRY 250 mg in 2 g ORAL POWDER [JBA GlucoTrojan]


name: DRESSING,OPSITE POST-OP 4 3/4IN X 4IN SN#66000710


name: DRESSING,AMD FOAM DISC 1IN CARDINAL #55512AMD


name: CATHERIZATION SET,INTERMITTENT 14FR C#28934


name: CATHETER,FOLEY SILICONE AG COATED 2-WAY 14FR 5ML DOVER #605148IC


name: Fora P20 Blood Pressure Cuff (Extra Large)


name: Pro Comfort Pressure Activated Safety Lancet 30G


name: VIVI Cap Insulin Temperature Shield Multi-Model Insulin Pen Cap


name: VIVI Epi Temperature Shield for Epinephrine Pen


name: {126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet) / 42 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet) } Pack


name: {126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet) / 210 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet) } Pack


name: {126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet) / 42 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet) / 84 (12 HR treprostinil 1 MG Extended Release Oral Tablet) } Pack


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [HEB SPF 50 Birthday Cake Continuous Sunscreen]


name: ZINC OXIDE 19 g in 100 g TOPICAL STICK [Baby Donna SHeer SPF Sunscreen Stick]


name: ZINC OXIDE 33 mg in 1 mL / TITANIUM DIOXIDE 59 mg in 1 mL TOPICAL LOTION [Babo Botanicals Daily Sheer Mineral Sunscreen SPF 40]


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) / 8 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) / 9 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {10 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) / 9 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) / 10 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {11 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) / 10 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) / 11 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {12 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) / 11 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) / 12 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {13 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {2 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) / 12 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {1 (5.5 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) / 13 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: {14 (8.3 ML onasemnogene abeparvovec-xioi 20000000000000 VECTOR-GENOMES/ML Injection) } Pack


name: ALUMINUM CHLOROHYDRATE 24.5 g in 100 g TOPICAL AEROSOL, SPRAY [Secret Weightless Dry Refreshing Berry plus Argan Oil]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [HEB SPF 50 Cucumber Water Scented Continuous Sunscreen]


name: COFFEE BEAN 16 g in 18 g / OPHIOCORDYCEPS SINENSIS 500 mg in 18 g / AMINO ACIDS, SOURCE UNSPECIFIED 200 mg in 18 g / CLUSTER FIG 100 mg in 18 g / MANGO 500 mg in 18 g / BANANA 500 mg in 18 g / WHITE MULBERRY 250 mg in 18 g ORAL POWDER [JBA Hello Healthy Glucose Coffee Healing Herbs for Blood Glucose Support With GlucoTrojan Reducose and ABALife Fig Extract]


name: COFFEE BEAN 17 g in 19 g / MARINE COLLAGEN, SOLUBLE 1000 mg in 19 g / AMINO ACIDS, SOURCE UNSPECIFIED 100 mg in 19 g / ALOE VERA LEAF 100 mg in 19 g / OPHIOCORDYCEPS SINENSIS 100 mg in 19 g / ELASTIN BOVINE 10 mg in 19 g / CURCULIGO ORCHIOIDES WHOLE 100 mg in 19 g / ASIAN GINSENG 100 mg in 19 g ORAL POWDER [JBA STANOMAX Caffe Latte Zero Sugar]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 20 g in 100 g TOPICAL GEL [Secret Clinical Clear Clean Coconut]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Sunscreen]


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 80 mg in 1 mL TOPICAL SOLUTION [RADIANCE Silky Mineral Primer Sunscreen SPF-42 HONEY]


name: ZINC OXIDE 145 mg in 1 g / OCTINOXATE 75 mg in 1 g TOPICAL LOTION [Replenix Tinted Sunscreen SPF 50]


name: ZINC OXIDE 120 mg in 1 mL TOPICAL SOLUTION [SEAWEED BATH CO. Clear Moisture Mineral SPF-30]


name: ZINC OXIDE 170 mg in 1 mL TOPICAL SOLUTION [SEAWEED BATH CO. Sheer Mineral Sensitive SPF-50]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20 g in 100 g TOPICAL STICK [Secret Clinical Invisible Clean Lavender]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20 g in 100 g TOPICAL STICK [Secret Clinical Invisible Free and Sensitive]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20 g in 100 g TOPICAL STICK [Secret Clinical Invisible Nurturing Coconut]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 20 g in 100 g TOPICAL STICK [Secret Clinical Invisible Stress Response]


name: ADENOSINE 0.04 g in 100 mL / NIACINAMIDE 2 g in 100 mL TOPICAL CREAM [DERMAHAN V10 WHITENING TONE UpCREAM]


name: COCOA 16 g in 18 g / OPHIOCORDYCEPS SINENSIS 500 mg in 18 g / AMINO ACIDS, SOURCE UNSPECIFIED 200 mg in 18 g / CLUSTER FIG 100 mg in 18 g / MANGO 500 mg in 18 g / BANANA 500 mg in 18 g / WHITE MULBERRY 250 mg in 18 g ORAL POWDER [JBA Hello Healthy Glucose Cacao Healing Herbs for Blood Glucose Support With GlucoTrojan Reducose and ABALife Fig Extract]


name: FARNESOL 3 mg in 100 g TOPICAL AEROSOL, SPRAY


name: Buffered C Powder Fruit Punch, Therapeutic Multiple Vitamins with Minerals oral powder for reconstitution


name: onasemnogene abeparvovec xioi 20 trillion vg/mL intravenous kit


name: dexAMETHasone sodium phosphate compounding powder


name: Banana Boat Sport Ultra SPF 100 Sunscreen


name: Cottonelle Ultra Comfort Care Toilet Paper


name: Dove Clean Comfort Antiperspirant Deodorant


name: Lysol Disinfectant Spray Spring Waterfall


name: Mini-Spike Dispensing Pin Needleless Filter


name: Olay Normal Moisturizer With Sunscreen SPF 15


name: Olay Total Effects Anti-Aging Sunscreen SPF15


name: Old Spice Fresh High Endurance Deodorant


name: Old Spice Pure Sport Deodorant Aluminum Free


name: Old Spice Pure Sport High Endurance Deodorant


name: Sidestream Pediatric Face Mask Latex-Free


name: Cream, Multi Ingredient Topical application Cream [Dermal K]


name: Titanium Dioxide/Zinc Oxide 9%-6% Topical application Lotion


name: Medical Food Oral Suspension [PKU Sphere20]


name: Medical Food Oral Suspension [Kindersprout Organic Plant-Based Protein Shake]


name: Ascorbic Acid/Botanical/Herb/Fiber/Fruit/Glucoraphanin/Probiotic Cultures/Vegetable 300 MG/1 SCOOPFUL-710 MG/1 SCOOPFUL-4.275 GM/1 SCOOPFUL-875 MG/1 SCOOPFUL-5 MG/1 SCOOPFUL-20 MG/1 SCOOPFUL-1.28 GM/1 SCOOPFUL Oral Powder for Solution [OrganiX Phytofood]


name: Calcium Alginate Topical application Dressing [Restore Calcium Alginate Dressing]


name: Egg 2 GM/1 SCOOPFUL Oral Powder [IG 26 DF]


name: Octisalate/Titanium Dioxide/Zinc Oxide;Titanium Dioxide/Zinc Oxide 5%-5.36%-10%; 8%-10% Topical application Lotion [Blue Lizard]


name: Ascorbic Acid/Botanical/Herb/Fiber/Fruit/Glucoraphanin/Probiotic Cultures/Vegetable 300 MG/1 SCOOPFUL-710 MG/1 SCOOPFUL-4.275 GM/1 SCOOPFUL-875 MG/1 SCOOPFUL-5 MG/1 SCOOPFUL-20 MG/1 SCOOPFUL-1.28 GM/1 SCOOPFUL Oral Powder for Solution


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Secret Nurturing Coconut Invisible]


name: diluent for insulin lispro and regular insulin INJECTION VIAL (ML)


name: diluent for measles,mumps,and rubella vacc (sterile water) SUBCUT SYRINGE (ML)


name: nutritional supplement 21 gram-170 kcal ORAL POWDER IN PACKET (EA)


name: nutritional supplement 24 gram-250 kcal ORAL POWDER IN PACKET (EA)


name: nutritional therapy for impaired digestive function 12 gram-469 kcal/100 gram ORAL POWDER (GRAM)


name: skin cleanser combination no.42 TOPICAL CLEANSER (ML)


name: skin cleanser combination no.44 TOPICAL CLEANSER (ML)


name: HOMOSALATE 9.8 g in 100 mL / OCTISALATE 4.9 g in 100 mL / AVOBENZONE 2.8 g in 100 mL / OCTOCRYLENE 9.5 g in 100 mL TOPICAL OIL [Vacation SPF 30 Baby Oil]


name: TITANIUM DIOXIDE 23.9 g in 100 g / ZINC OXIDE 24.1 g in 100 g TOPICAL POWDER [ROE wellness spf 50 mineral powder]


name: ZINC OXIDE 182.3 mg in 1 mL TOPICAL CREAM [LIVE TINTED Hueguard 3-in-1 Mineral Sunscreen Moisturizer Primer Broad Spectrum SPF 30]


name: atorvastatin, amlodipine and candesartan


name: levothyroxine sodium and iodine compounds


name: telmisartan, amlodipine and hydrochlorothiazide


name: Antineoplastic cell and gene therapy agents


name: HOMOSALATE 9.8 g in 100 mL / OCTISALATE 4.9 g in 100 mL / AVOBENZONE 2.9 g in 100 mL / OCTOCRYLENE 9.5 g in 100 mL TOPICAL OIL [Vacation SPF 30 Chardonnay Oil]


name: OCTOCRYLENE 9.5 g in 100 mL / OCTISALATE 4.9 g in 100 mL / AVOBENZONE 2.9 g in 100 mL TOPICAL SPRAY [Vacation SPF 50 Super Spritz Face Mist]


name: ZINC OXIDE 15.5 g in 100 mL TOPICAL LOTION [Vacation SPF 30 Mineral]


name: AVOBENZONE 15 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [HEB Oil Free Facial Moisturizer with Sunscreen Broad Spectrum SPF 15]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 25 mg in 1 mL TOPICAL SPRAY [HEB Solutions Sunscreen Face 50 Facial Mist Sunscreen]


name: ferric oxide polymaltose complexes and folic acid


name: AVOBENZONE 3 g in 100 mL / OCTISALATE 5 g in 100 mL / HOMOSALATE 4 g in 100 mL / OCTOCRYLENE 8 g in 100 mL TOPICAL LOTION [Glowscreen SPF 40 - Dawn]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [HEB SPF 50 Hydrate 50 Sunscreen with Hyaluronic Acid and Collagen Continuous Sunscreen]


name: HOMOSALATE 10 g in 100 g / OCTOCRYLENE 5 g in 100 g / OCTISALATE 5 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL LOTION [CorTex SunX 50 Thick]


name: HOMOSALATE 110 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [HEB Face Primer 30 Sunscreen Face Primer SPF 30]


name: TITANIUM DIOXIDE 12.25 mg in 1 mL / ZINC OXIDE 10.2 mg in 1 mL TOPICAL CREAM [Journee Firm Riche Broad Spectrum Sunscreen SPF 30]


name: ZINC OXIDE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL LOTION [HEB Face 50 Clear Zinc Sunscreen]


name: Brazilian pepper tree pollen extract / Peruvian pepper tree pollen extract


name: diluent for insulin lispro and regular insulin


name: diluent for measles, mumps, rubella vacc (water)


name: COCONUT OIL 0.5 g in 100 mL TOPICAL CREAM [LEBODY FIT BODY MASSAGER]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 50 mg in 1 g / OCTINOXATE 75 mg in 1 g TOPICAL AEROSOL, SPRAY [Bull Frog SPF 50 Mosquito Coast Sunscreen Plus Inspect Repellent]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 50 mg in 1 g TOPICAL AEROSOL, SPRAY [Bull Frog SPF 50 Quik with Water Armor Tech]


name: ferrous amino acid complex and folic acid


name: HOMOSALATE 110 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL GEL [Kroger Invisible Sunscreen SPF 40]


name: ZINC OXIDE 145 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [TOPCO TOPCARE EVERYDAY BABY PROTECTION SUN SPF 50]


name: ZINC OXIDE 150 mg in 1 g TOPICAL SPRAY [Topco Topcare Everyday Mineral Sunscreen Continuous SPF 30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL SPRAY [Kroger Sunscreen Oil SPF 50]


name: OCTISALATE 2.25 mg in 45 mL / AVOBENZONE 1.35 mg in 45 mL / HOMOSALATE 6.75 mg in 45 mL TOPICAL LOTION [Dr Lift Sun Care SPF 25]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL CREAM [Kroger Shimmer Sunscreen Hydrating SPF 40]


name: CAPSAICIN 0.14 g in 100 g TOPICAL CLOTH [Nufabrx Back Wrap]


name: CAPSAICIN 0.19 g in 100 g TOPICAL CLOTH [Nufabrx Neck Wrap]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 20 g in 100 g TOPICAL GEL [Secret Clinical Clear Completely Clean]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Secret Cozy Vanilla Invisible]


name: Octisalate/Titanium Dioxide/Zinc Oxide;Titanium Dioxide/Zinc Oxide 5%-5.36%-10%; 8%-10% Topical application Lotion


name: GCS NINDS Version 1.0 Clinical Classification Question


name: Glasgow Coma Scale-NINDS Version 1.0 Clinical Classification


name: Glasgow Coma Scale-NINDS Version 1.0 - Best Eye Response


name: Glasgow Coma Scale-NINDS Version 1.0 - Motor Response


name: Glasgow Coma Scale-NINDS Version 1.0 - Verbal Response


name: Glasgow Coma Scale-NINDS Version 1.0 - Total Score


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: GCS Accurate


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Paralytic


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Alcohol or Drug of Abuse


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: C-Spine Injury


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypoxia or Hypotension


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypothermia


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Sedation


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Unknown


name: PASI Feldman Version Clinical Classification Question


name: Psoriasis Area and Severity Index Feldman Version Clinical Classification


name: PASI Feldman Version - Head: Erythema/Redness


name: PASI Feldman Version - Head: Thickness/Induration


name: PASI Feldman Version - Head: Desquamation/Scaling


name: PASI Feldman Version - Upper Extremities: Erythema/Redness


name: PASI Feldman Version - Upper Extremities: Thickness/Induration


name: PASI Feldman Version - Upper Extremities: Area Score


name: PASI Feldman Version - Trunk: Erythema/Redness


name: PASI Feldman Version - Trunk: Thickness/Induration


name: PASI Feldman Version - Trunk: Desquamation/Scaling


name: PASI Feldman Version - Trunk: Area Score


name: PASI Feldman Version - Lower Extremities: Erythema/Redness


name: PASI Feldman Version - Lower Extremities: Thickness/Induration


name: PASI Feldman Version - Lower Extremities: Desquamation/Scaling


name: PASI Feldman Version - Lower Extremities: Area Score


name: PASI Feldman Version - Head: Sum of Symptom Scores


name: PASI Feldman Version - Head: Sum X Area X 0.1


name: PASI Feldman Version - Upper Extremities: Sum of Symptom Scores


name: PASI Feldman Version - Upper Extremities: Sum X Area


name: PASI Feldman Version - Upper Extremities: Sum X Area X 0.2


name: PASI Feldman Version - Trunk: Sum of Symptom Scores


name: PASI Feldman Version - Trunk: Sum X Area


name: PASI Feldman Version - Trunk: Sum X Area X 0.3


name: PASI Feldman Version - Lower Extremities: Sum of Symptom Scores


name: PASI Feldman Version - Lower Extremities: Sum X Area


name: PASI Feldman Version - Lower Extremities: Sum X Area X 0.4


name: CD95 Cell Surface Expression Measurement


name: HLA-DR Cell Surface Expression Measurement


name: Percent of Positive Tumor Infiltrating Immune Cells


name: Percent of Positive Tumor Infiltrating Lymphocytes


name: PD-L1 Expression Positive in Tumor Infiltrating Lymphocytes


name: Neuro-QOL Item Bank v2.0 Cognitive Function


name: How Much Current Difficulty Keeping Track of Time Question


name: How Much Current Difficulty Checking Accuracy of Financial Documents Question


name: How Much Current Difficulty Planning Activity Several Days in Advance Question


name: How Much Current Difficulty Getting Things Organized Question


name: How Much Current Difficulty Remembering Where Things Were Placed or Stored Question


name: How Much Current Difficulty Remembering Errands Without Writing them Down Question


name: How Often Make Simple Mistakes More Easily Question


name: How Often Words Seemed on the Tip of Tongue Question


name: How Often Had Trouble Keeping Track if Interrupted Question


name: How Often Had Difficulty Doing More than One Task Concurrently Question


name: How Often Had Trouble Remembering Whether I Did Things I was Supposed to Question


name: How Often Had Trouble Remembering New Information Question


name: How Often Walked into Room and Forgot Reason Question


name: How Often Had Trouble Remembering Name of Familiar Person Question


name: How Often Had Trouble Thinking Clearly Question


name: How Often Reacted Slowly to Things Said or Done Question


name: How Often Had Trouble Forming Thoughts Question


name: How Often Had Trouble Starting on Very Simple Tasks Question


name: How Often Had Trouble Making Decisions Question


name: How Often Had Trouble Planning Steps of Task Question


name: Have Difficulty with Steps or Stairs Question


name: Need Help with Household Chores Question


name: MRI-guided Intensity-Modulated Radiation Therapy


name: Rigid Gas Permeable Contact Lens Material


name: EndoPredict Breast Cancer Prognostic Test


name: Ophthalmic Tomography B-Scan Volume Analysis


name: Tumor Mutation Burden Less than One Mutation per Megabase


name: Lymphoblasts More than 10 Percent of Bone Marrow Nucleated Cells


name: Lymphoblasts More than 10 Percent of Peripheral Blood White Cells


name: Outsourcing Facility Compounded Human Drug Product (Not Marketed - Not Distributed)


name: MYCL Messenger RNA Expression Measurement


name: PD-L1 Expression Greater than or Equal to 50 Percent


name: Estrogen Receptor-Positive and Progesterone Receptor-Positive


name: Estrogen Receptor-Negative and Progesterone Receptor-Negative


name: CDISC SDTM Auricular Findings Test Name Terminology


name: CDISC SDTM Auricular Findings Test Code Terminology


name: CDISC SDTM Pediatric Findings About Test Name Terminology


name: CDISC SDTM Pediatric Findings About Test Code Terminology


name: CDISC Protocol Study Activity Attribute Terminology


name: Human Monkeypox Virus Measurement Finding


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0101 Standardized Character Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0102 Original Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0102 Standardized Character Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0104 Original Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0104 Standardized Character Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0105A Through HBI0105H Original Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0105A Through HBI0105H Standardized Character Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI101 Original Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI101 Standardized Character Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI102 Original Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI102 Standardized Character Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI103 Original Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI103 Standardized Character Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI104 Original Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI104 Standardized Character Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI105 Original Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI105 Standardized Character Response Terminology


name: CDISC Clinical Classification Rutgeerts Score RUTG0101 Original Response Terminology


name: CDISC Clinical Classification Rutgeerts Score RUTG0101 Standardized Character Response Terminology


name: Harvey-Bradshaw Index HBI0101 Question Clinical Classification Original Response


name: Harvey-Bradshaw Index HBI0102 Question Clinical Classification Original Response


name: Harvey-Bradshaw Index HBI0104 Question Clinical Classification Original Response


name: Harvey-Bradshaw Index HBI0105A Through HBI0105H Question Clinical Classification Original Response


name: Modified Van Assche Index MVAI101 Question Clinical Classification Original Response


name: Modified Van Assche Index MVAI102 Question Clinical Classification Original Response


name: Modified Van Assche Index MVAI103 Question Clinical Classification Original Response


name: Modified Van Assche Index MVAI104 Question Clinical Classification Original Response


name: Modified Van Assche Index MVAI105 Question Clinical Classification Original Response


name: Rutgeerts Score RUTG0101 Question Clinical Classification Original Response


name: Harvey-Bradshaw Index HBI0101 Question Clinical Classification Standardized Character Response


name: Harvey-Bradshaw Index HBI0102 Question Clinical Classification Standardized Character Response


name: Harvey-Bradshaw Index HBI0104 Question Clinical Classification Standardized Character Response


name: Harvey-Bradshaw Index HBI0105A Through HBI0105H Question Clinical Classification Standardized Character Response


name: Modified Van Assche Index MVAI101 Question Clinical Classification Standardized Character Response


name: Modified Van Assche Index MVAI102 Question Clinical Classification Standardized Character Response


name: Modified Van Assche Index MVAI103 Question Clinical Classification Standardized Character Response


name: Modified Van Assche Index MVAI104 Question Clinical Classification Standardized Character Response


name: Modified Van Assche Index MVAI105 Question Clinical Classification Standardized Character Response


name: Rutgeerts Score RUTG0101 Question Clinical Classification Standardized Character Response


name: CDISC Clinical Classification Harvey-Bradshaw Index Test Name Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index Test Code Terminology


name: CDISC Clinical Classification Montreal Classification for Crohn's Disease Test Name Terminology


name: CDISC Clinical Classification Montreal Classification for Crohn's Disease Test Code Terminology


name: CDISC Clinical Classification Modified Van Assche Index Test Name Terminology


name: CDISC Clinical Classification Modified Van Assche Index Test Code Terminology


name: CDISC Clinical Classification Rutgeerts Score Test Name Terminology


name: CDISC Clinical Classification Rutgeerts Score Test Code Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index Fredriksson Version Test Name Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index Fredriksson Version Test Code Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index European Medical Agency Version Test Name Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index European Medical Agency Version Test Code Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index Bozek Version Test Name Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index Bozek Version Test Code Terminology


name: CDISC Questionnaire Patient Health Questionnaire - 8 Item Test Name Terminology


name: CDISC Questionnaire Patient Health Questionnaire - 8 Item Test Code Terminology


name: CDISC Questionnaire Voice Handicap Index Test Name Terminology


name: CDISC Questionnaire Voice Handicap Index Test Code Terminology


name: Harvey-Bradshaw Index Clinical Classification Question


name: Montreal Classification for Crohn's Disease Clinical Classification Question


name: Modified Van Assche Index Clinical Classification Question


name: Rutgeerts Score Clinical Classification Question


name: Psoriasis Area and Severity Index Fredriksson Version Clinical Classification Question


name: Psoriasis Area and Severity Index European Medical Agency Version Clinical Classification Question


name: Psoriasis Area and Severity Index Bozek Version Clinical Classification Question


name: The Patient Health Questionnaire - 8 Item Questionnaire Question


name: Voice Handicap Index Questionnaire Question


name: Harvey-Bradshaw Index HBI0101 Original Result - Very Well


name: Harvey-Bradshaw Index HBI0101 Original Result - Slightly Below Par


name: Harvey-Bradshaw Index HBI0101 Original Result - Poor


name: Harvey-Bradshaw Index HBI0101 Original Result - Very Poor


name: Harvey-Bradshaw Index HBI0101 Original Result - Terrible


name: Harvey-Bradshaw Index HBI0101 Standardized Character Result 0


name: Harvey-Bradshaw Index HBI0101 Standardized Character Result 1


name: Harvey-Bradshaw Index HBI0101 Standardized Character Result 2


name: Harvey-Bradshaw Index HBI0101 Standardized Character Result 3


name: Harvey-Bradshaw Index HBI0101 Standardized Character Result 4


name: Harvey-Bradshaw Index HBI0102 Original Result - None


name: Harvey-Bradshaw Index HBI0102 Original Result - Mild


name: Harvey-Bradshaw Index HBI0102 Original Result - Moderate


name: Harvey-Bradshaw Index HBI0102 Original Result - Severe


name: Harvey-Bradshaw Index HBI0102 Standardized Character Result 0


name: Harvey-Bradshaw Index HBI0102 Standardized Character Result 1


name: Harvey-Bradshaw Index HBI0102 Standardized Character Result 2


name: Harvey-Bradshaw Index HBI0102 Standardized Character Result 3


name: Harvey-Bradshaw Index HBI0104 Original Result - None


name: Harvey-Bradshaw Index HBI0104 Original Result - Dubious


name: Harvey-Bradshaw Index HBI0104 Original Result - Definite


name: Harvey-Bradshaw Index HBI0104 Original Result - Definite and Tender


name: Harvey-Bradshaw Index HBI0104 Standardized Character Result 0


name: Harvey-Bradshaw Index HBI0104 Standardized Character Result 1


name: Harvey-Bradshaw Index HBI0104 Standardized Character Result 2


name: Harvey-Bradshaw Index HBI0104 Standardized Character Result 3


name: Harvey-Bradshaw Index HBI0105A Through HBI0105H Original Result - No


name: Harvey-Bradshaw Index HBI0105A Through HBI0105H Original Result - Yes


name: Harvey-Bradshaw Index HBI0105A Through HBI0105H Standardized Character Result 0


name: Harvey-Bradshaw Index HBI0105A Through HBI0105H Standardized Character Result 1


name: Modified Van Assche Index MVAI101 Original Result - Absent


name: Modified Van Assche Index MVAI101 Original Result - Infralevatoric


name: Modified Van Assche Index MVAI101 Original Result - Horseshoe Configuration


name: Modified Van Assche Index MVAI101 Original Result - Supralevatoric


name: Modified Van Assche Index MVAI101 Standardized Character Result 0


name: Modified Van Assche Index MVAI101 Standardized Character Result 1


name: Modified Van Assche Index MVAI101 Standardized Character Result 2


name: Modified Van Assche Index MVAI101 Standardized Character Result 3


name: Modified Van Assche Index MVAI102 Original Result - Absent


name: Modified Van Assche Index MVAI102 Original Result - Mild


name: Modified Van Assche Index MVAI102 Original Result - Pronounced


name: Modified Van Assche Index MVAI102 Standardized Character Result 0


name: Modified Van Assche Index MVAI102 Standardized Character Result 1


name: Modified Van Assche Index MVAI102 Standardized Character Result 2


name: Modified Van Assche Index MVAI103 Original Result - Normal


name: Modified Van Assche Index MVAI103 Original Result - Thickened


name: Modified Van Assche Index MVAI103 Original Result - Increased Signal Intensity


name: Modified Van Assche Index MVAI103 Standardized Character Result 0


name: Modified Van Assche Index MVAI103 Standardized Character Result 1


name: Modified Van Assche Index MVAI103 Standardized Character Result 2


name: Modified Van Assche Index MVAI104 Original Result - Absent


name: Modified Van Assche Index MVAI104 Original Result - Diffuse


name: Modified Van Assche Index MVAI104 Original Result - Focal


name: Modified Van Assche Index MVAI104 Original Result - Collection - Small


name: Modified Van Assche Index MVAI104 Original Result - Collection - Medium


name: Modified Van Assche Index MVAI104 Original Result - Collection - Large


name: Modified Van Assche Index MVAI104 Standardized Character Result 0


name: Modified Van Assche Index MVAI104 Standardized Character Result 1


name: Modified Van Assche Index MVAI104 Standardized Character Result 2


name: Modified Van Assche Index MVAI104 Standardized Character Result 3


name: Modified Van Assche Index MVAI104 Standardized Character Result 4


name: Modified Van Assche Index MVAI104 Standardized Character Result 5


name: Modified Van Assche Index MVAI105 Original Result - Fibrous


name: Modified Van Assche Index MVAI105 Original Result - Granulation Tissue


name: Modified Van Assche Index MVAI105 Original Result - Fluid/Pus


name: Modified Van Assche Index MVAI105 Standardized Character Result 0


name: Modified Van Assche Index MVAI105 Standardized Character Result 1


name: Modified Van Assche Index MVAI105 Standardized Character Result 2


name: Rutgeerts Score RUTG0101 Original Result - No Lesions


name: Rutgeerts Score RUTG0101 Original Result - Less Than 5 Aphthous Lesions


name: Rutgeerts Score RUTG0101 Original Result - Greater Than 5 Aphthous Lesions With Normal Mucosa Between the Lesions, or Skip Areas of Larger Lesions or Lesions Confined to the Ileocolonic Anastomosis (i.e., Less Than 1 cm in Length)


name: Rutgeerts Score RUTG0101 Original Result - Diffuse Aphthous Ileitis With Diffusely Inflamed Mucosa


name: Rutgeerts Score RUTG0101 Original Result - Diffuse Inflammation With Already Larger Ulcers, Nodules, and/or Narrowing


name: Rutgeerts Score RUTG0101 Standardized Character Result i0


name: Rutgeerts Score RUTG0101 Standardized Character Result i1


name: Rutgeerts Score RUTG0101 Standardized Character Result i2


name: Rutgeerts Score RUTG0101 Standardized Character Result i3


name: Rutgeerts Score RUTG0101 Standardized Character Result i4


name: Harvey-Bradshaw Index Clinical Classification


name: Montreal Classification for Crohn's Disease Clinical Classification


name: Modified Van Assche Index Clinical Classification


name: Psoriasis Area and Severity Index Fredriksson Version Clinical Classification


name: Psoriasis Area and Severity Index European Medical Agency Version Clinical Classification


name: Psoriasis Area and Severity Index Bozek Version Clinical Classification


name: HBI - Complication: Pyoderma Gangrenosum


name: Montreal Classification - Age at Diagnosis


name: MVAI - Hyperintensity T2-weighted Images


name: PASI Fredriksson Version - Head: Erythema/Redness


name: PASI Fredriksson Version - Head: Thickness/Induration


name: PASI Fredriksson Version - Head: Desquamation/Scaling


name: PASI Fredriksson Version - Head: Area Score


name: PASI Fredriksson Version - Upper Extremities: Erythema/Redness


name: PASI Fredriksson Version - Upper Extremities: Thickness/Induration


name: PASI Fredriksson Version - Upper Extremities: Desquamation/Scaling


name: PASI Fredriksson Version - Upper Extremities: Area Score


name: PASI Fredriksson Version - Trunk: Erythema/Redness


name: PASI Fredriksson Version - Trunk: Thickness/Induration


name: PASI Fredriksson Version - Trunk: Desquamation/Scaling


name: PASI Fredriksson Version - Trunk: Area Score


name: PASI Fredriksson Version - Lower Extremities: Erythema/Redness


name: PASI Fredriksson Version - Lower Extremities: Thickness/Induration


name: PASI Fredriksson Version - Lower Extremities: Desquamation/Scaling


name: PASI Fredriksson Version - Lower Extremities: Area Score


name: PASI Fredriksson Version - Head: Sum of Symptom Scores


name: PASI Fredriksson Version - Head: Sum X Area


name: PASI Fredriksson Version - Head: Sum X Area X 0.1


name: PASI Fredriksson Version - Upper Extremities: Sum of Symptom Scores


name: PASI Fredriksson Version - Upper Extremities: Sum X Area


name: PASI Fredriksson Version - Upper Extremities: Sum X Area X 0.2


name: PASI Fredriksson Version - Trunk: Sum of Symptom Scores


name: PASI Fredriksson Version - Trunk: Sum X Area


name: PASI Fredriksson Version - Trunk: Sum X Area X 0.3


name: PASI Fredriksson Version - Lower Extremities: Sum of Symptom Scores


name: PASI Fredriksson Version - Lower Extremities: Sum X Area


name: PASI Fredriksson Version - Lower Extremities: Sum X Area X 0.4


name: PASI EMA Version - Head: Erythema/Redness


name: PASI EMA Version - Head: Thickness/Induration


name: PASI EMA Version - Head: Desquamation/Scaling


name: PASI EMA Version - Upper Extremities: Erythema/Redness


name: PASI EMA Version - Upper Extremities: Thickness/Induration


name: PASI EMA Version - Upper Extremities: Desquamation/Scaling


name: PASI EMA Version - Upper Extremities: Area Score


name: PASI EMA Version - Trunk: Erythema/Redness


name: PASI EMA Version - Trunk: Thickness/Induration


name: PASI EMA Version - Trunk: Desquamation/Scaling


name: PASI EMA Version - Lower Extremities: Erythema/Redness


name: PASI EMA Version - Lower Extremities: Thickness/Induration


name: PASI EMA Version - Lower Extremities: Desquamation/Scaling


name: PASI EMA Version - Lower Extremities: Area Score


name: PASI EMA Version - Head: Sum of Symptom Scores


name: PASI EMA Version - Head: Sum X Area X 0.1


name: PASI EMA Version - Upper Extremities: Sum of Symptom Scores


name: PASI EMA Version - Upper Extremities: Sum X Area


name: PASI EMA Version - Upper Extremities: Sum X Area X 0.2


name: PASI EMA Version - Trunk: Sum of Symptom Scores


name: PASI EMA Version - Trunk: Sum X Area X 0.3


name: PASI EMA Version - Lower Extremities: Sum of Symptom Scores


name: PASI EMA Version - Lower Extremities: Sum X Area


name: PASI EMA Version - Lower Extremities: Sum X Area X 0.4


name: PASI Bozek Version - Head: Erythema/Redness


name: PASI Bozek Version - Head: Thickness/Induration


name: PASI Bozek Version - Head: Desquamation/Scaling


name: PASI Bozek Version - Upper Extremities: Erythema/Redness


name: PASI Bozek Version - Upper Extremities: Thickness/Induration


name: PASI Bozek Version - Upper Extremities: Desquamation/Scaling


name: PASI Bozek Version - Upper Extremities: Area Score


name: PASI Bozek Version - Trunk: Erythema/Redness


name: PASI Bozek Version - Trunk: Thickness/Induration


name: PASI Bozek Version - Trunk: Desquamation/Scaling


name: PASI Bozek Version - Lower Extremities: Erythema/Redness


name: PASI Bozek Version - Lower Extremities: Thickness/Induration


name: PASI Bozek Version - Lower Extremities: Desquamation/Scaling


name: PASI Bozek Version - Lower Extremities: Area Score


name: PASI Bozek Version - Head: Sum of Symptom Scores


name: PASI Bozek Version - Head: Sum X Area X 0.1


name: PASI Bozek Version - Upper Extremities: Sum of Symptom Scores


name: PASI Bozek Version - Upper Extremities: Sum X Area


name: PASI Bozek Version - Upper Extremities: Sum X Area X 0.2


name: PASI Bozek Version - Trunk: Sum of Symptom Scores


name: PASI Bozek Version - Trunk: Sum X Area X 0.3


name: PASI Bozek Version - Lower Extremities: Sum of Symptom Scores


name: PASI Bozek Version - Lower Extremities: Sum X Area


name: PASI Bozek Version - Lower Extremities: Sum X Area X 0.4


name: PHQ-8 - Little Interest or Pleasure in Things


name: PHQ-8 - Feeling Down Depressed or Hopeless


name: PHQ-8 - Trouble Falling or Staying Asleep


name: PHQ-8 - Moving Slowly or Fidgety or Restless


name: VHI - People Difficulty Understanding Me


name: VHI - Speak Friends Less Often Because Voice


name: VHI - Left Out of Conversation Because Voice


name: VHI - People Ask What's Wrong With Voice


name: VHI - Tense Talking to Others Because Voice


name: VHI - People Seem Irritated With My Voice


name: VHI - People Don't Understand Voice Problem


name: VHI - Less Outgoing Because of Voice Problem


name: ACC-AHA Cardiovascular and Noncardiovascular Complications of COVID-19 Terminology


name: Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Helper 17.1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Regulatory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Central Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Follicular Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Regulatory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: CEA Cell Adhesion Molecule 5 Measurement


name: Bioresearch Monitoring Technical Conformance Guide


name: Stem Cell Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Stem Cell Memory Cytotoxic T-Lymphocyte to Naive Cytotoxic T-Lymphocyte Ratio Measurement


name: Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Ki67 Cell Surface Expression Measurement


name: Helper 17.1 T-Lymphocyte Subpopulation to Helper 17.1 T-Lymphocyte Ratio Measurement


name: Helper 17.1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper 17 T-Lymphocyte Subpopulation to Helper 17 T-Lymphocyte Ratio Measurement


name: Helper 17 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Helper 17 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper 1 T-Lymphocyte Subpopulation to Helper 1 T-Lymphocyte Ratio Measurement


name: Helper 1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Helper 1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper 22 T-Lymphocyte Subpopulation to Helper 22 T-Lymphocyte Ratio Measurement


name: Helper 22 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Helper 22 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper 2 T-Lymphocyte Subpopulation to Helper 2 T-Lymphocyte Ratio Measurement


name: Helper 2 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Helper 2 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper 9 T-Lymphocyte Subpopulation to Helper 9 T-Lymphocyte Ratio Measurement


name: Helper 9 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Helper 9 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Naive Helper Regulatory T-Lymphocyte Subpopulation to Helper Regulatory T-Lymphocyte Ratio Measurement


name: Stem Cell Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Stem Cell Memory Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement


name: Effector Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Cytotoxic T-Lymphocytes to Lymphocytes Ratio Measurement


name: Naive Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Regulatory Cytotoxic T-Lymphocyte Subpopulation to Regulatory Cytotoxic T-Lymphocyte Ratio Measurement


name: Regulatory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Stem Cell Memory Cytotoxic T-Lymphocyte Count


name: Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation Count


name: Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Stem Cell Memory Cytotoxic T-Lymphocyte Ratio Measurement


name: Cytotoxic T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement


name: Central Memory Helper T-Lymphocyte Subpopulation to Central Memory Helper T-Lymphocyte Ratio Measurement


name: Central Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Effector Memory Helper T-Lymphocyte Subpopulation to Effector Memory Helper T-Lymphocyte Ratio Measurement


name: Effector Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Effector Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Follicular Helper T-Lymphocyte Subpopulation Count


name: Follicular Helper T-Lymphocyte Subpopulation to Follicular Helper T-Lymphocyte Ratio Measurement


name: Follicular Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper T-Lymphocyte to Lymphocyte Ratio Measurement


name: Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Naive Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement


name: Naive Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Naive Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Regulatory Memory Helper T-Lymphocyte Subpopulation to Regulatory Memory Helper T-Lymphocyte Ratio Measurement


name: Regulatory Memory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement


name: Naive Regulatory Helper T-Lymphocyte Subpopulation to Naive Regulatory Helper T-Lymphocyte Ratio Measurement


name: Naive Regulatory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement


name: Regulatory Helper T-Lymphocyte Subpopulation to Regulatory Helper T-Lymphocyte Ratio Measurement


name: Eighty Percent Neutralization Endpoint Titer


name: Fifty Percent Plaque Reduction Neutralization Endpoint Titer


name: Fifty Percent Focus Reduction Neutralization Titer


name: Lysosome-Associated Membrane Protein 2 Measurement


name: Lysosomal Associated Membrane Protein 2 to Glyceraldehyde-3-Phosphate Dehydrogenase Ratio Measurement


name: Soluble CEA Cell Adhesion Molecule 5 Measurement


name: Wild Type Huntingtin Protein Measurement


name: Synoviocytes to Leukocytes Ratio Measurement


name: Acinetobacter calcoaceticus/baumannii Complex DNA Measurement


name: Acinetobacter calcoaceticus/baumannii Complex Measurement


name: Enterobacter cloacae Complex DNA Measurement


name: Enterobacter cloacae Complex Measurement


name: Human Parainfluenza virus RNA Measurement


name: Hematopoietic Cells to Adipocytes Ratio Measurement


name: MDS/MPN IWC Savona 2015 Oncology Response Criteria


name: Elapsed Time Since Last Menstrual Period


name: Spot Forming Units Per Ten Thousand Peripheral Blood Mononuclear Cells


name: Spot Forming Units Per Twenty Thousand Peripheral Blood Mononuclear Cells


name: Extracellular Water to Total Body Water Ratio Measurement


name: Appendix 3: COVID-19 Diagnosis Terminology


name: Appendix 4: COVID-19 Cardiovascular Complications Terminology


name: Appendix 5: COVID-19 Noncardiovascular Complications Terminology


name: Appendix 6: Symptoms and Signs Terminology


name: Appendix 7: Diagnostic Procedures Terminology


name: Appendix 8: Pharmacological Therapy Terminology


name: Appendix 9: Therapeutic and Supportive Procedures for COVID-19 Terminology


name: Appendix 10: End-of-Life Management Terminology


name: Acute Cardiovascular Complications Related to COVID-19 Infection Terminology


name: Cardiovascular Mortality During Acute COVID-19 Infection Terminology


name: Current Symptoms and Signs: Clinical Symptoms Terminology


name: Invasive Coronary/Vascular/Neurovascular Revascularization Treatment Terminology


name: Postacute Cardiovascular Sequelae of SARS-CoV-2 Infection or Long-Term Cardiovascular Complications of COVID-19 Terminology


name: Therapies for Preexisting Cardiovascular Disease (Patient Taking Prior to Admission) Terminology


name: Therapies for Supportive Care During COVID-19 Infection Terminology


name: Cardiovascular Mortality During Acute COVID-19


name: Coronary Artery Disease Reporting and Data System Coronary CT Angiography Score


name: COVID-19-specific Anticoagulation Dosing Strategy


name: Cardiovascular Adverse Events Related to Medications Aimed at COVID-19


name: Death due to Cardiovascular Hemorrhage Related to COVID-19


name: Death due to Other Cardiovascular Cause Related to COVID-19


name: Implantation of Long Term Durable Mechanical Circulatory Support Device


name: Implantation of Temporary Mechanical Circulatory Support Device


name: Temporary Transvenous Pacing Wire Placement


name: Preexisting Cardiovascular Disease Therapy


name: Death due to Acute Myocardial Infarction Related to COVID-19


name: Type of Permanent Cardioverter-Defibrillator Implanted Question


name: Coronary Artery Disease Reporting and Data System Coronary CT Angiography Score 0


name: Coronary Artery Disease Reporting and Data System Coronary CT Angiography Score 1


name: Coronary Artery Disease Reporting and Data System Coronary CT Angiography Score 2


name: Coronary Artery Disease Reporting and Data System Coronary CT Angiography Score 3


name: Coronary Artery Disease Reporting and Data System Coronary CT Angiography Score 4


name: Coronary Artery Disease Reporting and Data System Coronary CT Angiography Score 5


name: COVID-19-specific Full Anticoagulation Dose


name: COVID-19-specific Intermediate Anticoagulation Dose


name: Date of Cardiopulmonary Resuscitation for Cardiac Arrest


name: Date of First COVID-19-related Hospitalization


name: Date of First Hospitalization with Incidental Diagnosis of SARS-CoV-2 Infection


name: Date of Cardioverter-Defibrillator Implantation


name: Date of Percutaneous Coronary Intervention


name: Date of Temporary Transvenous Pacing Wire Insertion


name: Death due to Heart Failure Related to COVID-19


name: Death due to Pulmonary Embolus Related to COVID-19


name: Bioabsorbable Polymer-Coated Drug Eluting Stent


name: Hospitalization with Incidental Diagnosis of SARS-CoV-2 Infection


name: Myocardial Edema by T2 Mapping or T2-weighted Imaging


name: Myocardial Injury by Late Gadolinium Enhancement of T1 Imaging


name: Manufacturer of SARS-CoV-2 Vaccine Received


name: Percutaneous Coronary Intervention Status


name: Salvage Percutaneous Coronary Intervention


name: Urgent Percutaneous Coronary Intervention


name: Catheter-based Miniaturized Left Ventricular Assist Device


name: Prior COVID-19 Infection With Residual Sequelae of Post-Acute COVID-19


name: Prior COVID-19 Infection Without Residual Sequelae of Post-Acute COVID-19


name: Sudden Cardiac Death Related to COVID-19


name: Sudden Cardiac Death with Return of Spontaneous Circulation Related to COVID-19


name: Thrombectomy for Peripheral Arterial Thrombus


name: Time of Cardiopulmonary Resuscitation for Cardiac Arrest


name: Time of Percutaneous Coronary Intervention


name: ACC-AHA COVID-19 Appendix Authorized Values


name: Regimen Used to Treat Appendiceal Cancer


name: Regimen Used to Treat Salivary Gland Tumor


name: PSA Doubling Time Greater than or Equal to 4 Months


name: Dose-dense AC Followed by Dose-Dense Paclitaxel/Trastuzumab Regimen


name: Regimen Used to Treat Pre-malignant Disorder


name: Therapeutic Globin Gene Level Expression Analysis


name: Three-Dimensional Dynamic Intensity Entropy Transformation Magnetic Resonance Imaging


name: Unfavorable Intermediate Risk Prostate Carcinoma


name: Favorable Intermediate Risk Prostate Carcinoma


name: Prior Radiation Therapy of Thoracic Region


name: Infertility Related to Medical Condition


name: Large Malignant Glands Lined with Pseudostratified Epithelium Present


name: Neuro QOL Item Bank v2.0 - Pediatric Cognitive Function


name: Forget Schoolwork that Needs to be Done Question


name: Sometimes Forget What was Going to Say Question


name: React Slower than Most People My Age Question


name: Have Trouble Remembering to do Things Question


name: Have Trouble Paying Attention to Teacher Question


name: Have to Work Hard to Pay Attention or Will Make a Mistake Question


name: Bevacizumab/Cisplatin/Pemetrexed Followed by Bevacizumab Regimen


name: Bevacizumab/Carboplatin/Pemetrexed Followed by Bevacizumab Regimen


name: Neuro QOL Pediatric Mental Health Domain


name: Felt Everything in My Life Went Wrong Question


name: Could Do Sports and Exercise Other Kids Same Age Could Do Question


name: Could Walk Up Stairs Unassisted Question


name: Physically Able to Do Activities I Enjoy Most Question


name: Emotional Distress - Anxiety Subordinate Domain


name: Emotional Distress - Depressive Symptoms Subordinate Domain


name: Sleep-Related Disturbance Subordinate Domain


name: Physical Function - Mobility Subordinate Domain


name: PROMIS Pediatric and Parent Proxy Mental Health Domain


name: Extent that Dry Mouth Interfered with Usual Activities Question


name: Frequency of Mouth or Throat Pain Question


name: Extent that Mouth or Throat Pain Interfered with Usual Activities Question


name: Extent that Change in Taste of Food or Drink Interfered with Eating Usual Food Question


name: Extent that Nausea Interfered with Usual Activities Question


name: Extent that Vomiting Interfered with Usual Activities Question


name: Extent that Constipation Interfered with Usual Activities Question


name: Extent that Diarrhea Interfered with Usual Activities Question


name: Extent that Stomach Pain Interfered with Usual Activities Question


name: Extent that Coughing Interfered with Usual Activities Question


name: Extent that Itchy Skin Interfered with Usual Activities Question


name: Extent that Hand or Foot Numbness or Tingling Interfered with Usual Activities Question


name: Extent that Muscle Pain Interfered with Usual Activities Question


name: Extent that Joint Pain Interfered with Usual Activities Question


name: Presence of Open Sores or Red Spots Question


name: Amivantamab and Recombinant Human Hyaluronidase


name: 4-Dimensional Magnetic Resonance Imaging


name: Medical Product Dispensation- or Prescription-Related Activity


name: Severity of Mouth or Throat Pain Question


name: Report Treatment Discontinuation or Transfer of Care


name: Establish Processes and Procedures to Notify


name: Establish Processes and Procedures to Provide


name: Do Not Dispense Outside of Specified Facility


name: Patient Must have a Specified Item or Intervention


name: Distribute Only to Certified Healthcare Provider or Setting


name: Have Someone Who Makes Me Feel Appreciated Question


name: Decreased Levels of HLA Class I Panel Reactive Antibody


name: Activating RAF Family Alteration Positive


name: Operational Ontology for Radiation Oncology Terminology


name: Operational Ontology for Radiation Oncology Prostate Cancer Terminology


name: Intensity Modulated Radiation Therapy Leaf Motion


name: Inter-fraction Adaptation of Treatment Plan


name: Intra-fraction Adaptation of Treatment Plan


name: Age at Report at Diagnosis and Staging of Prostate Cancer


name: Age at Report of Androgen Deprivation Therapy


name: Age at Report of Interventional Procedure


name: Age at Report of Patient Reported Outcome


name: Age at Report of Patient Treatment Outcome


name: Age at Report of Provider Reported Toxicity


name: Age at Report of Radiation Therapy Course


name: Age at Report of Radiation Therapy Course Event


name: Age at Report of Radiation Therapy Course Session


name: Age at Report of Radiation Therapy Prescription


name: Age at Report of Reirradiation Evaluation


name: Age at Report of Systemic Therapy Course


name: Age at Report of Treated Field in Treated Radiation Therapy Plan Fraction


name: Age at Report of Treated Radiation Therapy Plan


name: Date of Report at Diagnosis and Staging of Prostate Cancer


name: Multiple Static Segments Radiation Therapy Delivery Method


name: Automated Multi-Institution Validated - Atlas Based Planning Structure Generation


name: Automated Multi-Institution Validated - Algorithm Based Planning Structure Generation


name: Automated Multi-Institution Validated - Artificial Intelligence/Machine Learning Planning Structure Generation


name: Automated Single Institution Validated - Atlas Based Planning Structure Generation


name: Automated Single Institution Validated - Algorithm Based Planning Structure Generation


name: Automated Single Institution Validated - Artificial Intelligence/Machine Learning Planning Structure Generation


name: Automated Commercial Radiotherapy Treatment Planning System


name: Automated In-House Radiotherapy Treatment Planning System


name: Fixed Basis Relative Biological Effectiveness


name: LET-based Relative Biological Effectiveness


name: Variable Biologic Model-based Relative Biological Effectiveness


name: Patient-reported Outcome Question Response


name: Radiation Therapy was Palliative Therapy


name: Radiation Therapy was Supportive Therapy


name: Breath Control Used as Part of Treatment Question


name: Diagnostic Imaging Used for M Staging Question


name: Diagnostic Imaging Used for N Staging Question


name: Diagnostic Imaging Used for T Staging Question


name: Fiducial Markers Used for Image Guidance Question


name: Has Ever Been in a Clinical Trial Question


name: Heterogeneity Correction Used in Dose Calculation Question


name: How Likely is Death Related to Treatment Question


name: Imaging Captured to Calculate Treatment Session Dose and Compare to Original Plan Question


name: Intervention Performed Prior to Radiation Therapy Question


name: Patient Language Used in Encounter Question


name: Planned Dose is Sum of Other Plan Doses Question


name: Prescription Specifies Dose Objectives For Single Course Question


name: Prescription Specifies Dose Objectives For Single Phase Question


name: Prescription Specifies Dose Objectives For Single Treatment Plan Question


name: Primary ICD Codes When Treating Secondary Question


name: Primary Organs Directing Registration Question


name: Quantitative Dose Calculations Performed to Evaluate Cumulative Doses Question


name: Radiation Field for Current Course Overlaps with Prior Courses Question


name: Structure Type is Target Structure or Organ at Risk Question


name: Which Breath Control Methods Used Question


name: Systemic Therapy Administration Frequency


name: Patient-reported Outcome Question Identifier


name: Duration of Radiation Delivery in Session


name: Duration of Treating Field Radiation in Fraction


name: Duration of Treating Plan Radiation in Fraction


name: Date of Report of Androgen Deprivation Therapy


name: Date of Report of Interventional Procedure


name: Date of Report of Patient Reported Outcome


name: Date of Report of Patient Treatment Outcome


name: Date of Report of Provider Reported Toxicity


name: Date of Report of Radiation Therapy Course


name: Date of Report of Radiation Therapy Course Event


name: Date of Report of Radiation Therapy Course Session


name: Date of Report of Radiation Therapy Prescription


name: Date of Report of Reirradiation Evaluation


name: Date of Report of Systemic Therapy Course


name: Date of Report of Systemic Therapy Cycle


name: Date of Report of Treated Field in Treated Radiation Therapy Plan Fraction


name: Date of Report of Treated Radiation Therapy Plan


name: Uniform Active Scanning Proton Beam Therapy


name: Moderately Hypofractionated Radiation Therapy


name: Recurrence of CHAARTED High Volume Metastatic Disease


name: Recurrence of CHAARTED Low Volume Metastatic Disease


name: Recurrence of Primary in Seminal Vesicles


name: Tertiary Gleason Pattern at Prostatectomy


name: Secondary Gleason Pattern at Prostatectomy


name: Primary Gleason Pattern at Prostatectomy


name: GPS Coordinates of Intervention Facility


name: Adaptation or Revision of Treatment Plan Name


name: Radiation Oncology Information System Plan Name


name: Fraction of Plan Dose Associated with Field


name: Number of Prescribed Radiation Therapy Sessions


name: Carbon-11 Choline Positron Emission Tomography


name: F-18 Fluciclovine Positron Emission Tomography


name: Patient Transferred to Different Institution


name: Radiotherapy Course Changed due to Toxicity


name: Treatment Break Due to Patient Non-Toxicity


name: Treatment Missed due to Patient Being Unable to Secure Dependent Care


name: Treatment Missed due to Patient Being Unable to Secure Time Away from Work


name: Treatment Missed due to Patient Lacking Transportation


name: Hybrid Intracavitary and Interstitial Brachytherapy


name: Standardized Minimal Time Before Time Repair Weighting Factor


name: Health Equity Achievement in Radiation Therapy Score


name: Laboratory-Confirmed Human Monkeypox Infection


name: International Soft Tissue Sarcoma Consortium


name: International Pediatric Acute Myeloid Leukemia Consortium


name: Global Retinoblastoma Alliance for Children


name: Consortium for Childhood Cancer Predisposition


name: Japan Children's Cancer Group Neuroblastoma Committee


name: International Society of Paediatric Oncology Europe Neuroblastoma Group


name: European Paediatric Soft Tissue Sarcoma Study Group


name: European Society for Paediatric Oncology


name: Defining Platforms for Individualized Cancer Treatment


name: MET/CEP7 Ratio Greater than or Equal to 4


name: CELLOSAURUS Resistance and Transformant Physical Factor Terminology


name: Ki-67 Positive Cells Greater than or Equal to 3 Percent


name: NCCN Prostate Cancer Very Low Risk Group


name: NCCN Prostate Cancer Intermediate Risk Group


name: NCCN Prostate Cancer Favorable-Intermediate Risk Group


name: NCCN Prostate Cancer Unfavorable-Intermediate Risk Group


name: NCCN Prostate Cancer Very High Risk Group


name: Japanese Infantile Neuroblastoma Collaborative Study Group


name: mCode Benign Neoplasm of Brain and CNS Disorder Value Set


name: mCode Body Location and Laterality Qualifier Value Set


name: mCode Brachytherapy High Dose Rate Electronic Technique Value Set


name: mCode Brachytherapy High Dose Rate Technique Value Set


name: mCode Brachytherapy Low Dose Rate Temporary Radation Technique Value Set


name: mCode Brachytherapy Permanent Seeds Technique Value Set


name: mCode Brachytherapy Pulsed Dose Rate Technique Value Set


name: mCode Brachytherapy Radiopharmaceutical Technique Value Set


name: mCode Carcinoma In-Situ Disorder Value Set


name: mCode Cytologic Evidence of Malignancy Value Set


name: mCode Histology Morphology Behavior Value Set


name: mCode Specific Diagnosis of Cancer Value Set


name: mCode Melanoma In-Situ Disorder Value Set


name: mCode Primary Malignant Neoplasm Disorder Value Set


name: mCode Secondary Cancer Disorder Value Set


name: mCode Teleradiotherapy Modality Value Set


name: mCode Teleradiotherapy Technique Value Set


name: CDISC Clinical Classification Tanner Scale Girl TANN0101 Original Response Terminology


name: CDISC Clinical Classification Tanner Scale Girl TANN0101 Standardized Character Response Terminology


name: CDISC Clinical Classification Tanner Scale Girl TANN0102 Original Response Terminology


name: CDISC Clinical Classification Tanner Scale Girl TANN0102 Standardized Character Response Terminology


name: CDISC Clinical Classification Tanner Scale Boy TANN0201 Original Response Terminology


name: CDISC Clinical Classification Tanner Scale Boy TANN0201 Standardized Character Response Terminology


name: CDISC Clinical Classification Tanner Scale Boy TANN0202 Original Response Terminology


name: CDISC Clinical Classification Tanner Scale Boy TANN0202 Standardized Character Response Terminology


name: Tanner Scale Girl TANN0101 Question Clinical Classification Original Response


name: Tanner Scale Girl TANN0101 Question Clinical Classification Standardized Character Response


name: Tanner Scale Girl TANN0102 Question Clinical Classification Original Response


name: Tanner Scale Girl TANN0102 Question Clinical Classification Standardized Character Response


name: Tanner Scale Boy TANN0201 Question Clinical Classification Original Response


name: Tanner Scale Boy TANN0201 Question Clinical Classification Standardized Character Response


name: Tanner Scale Boy TANN0202 Question Clinical Classification Original Response


name: Tanner Scale Boy TANN0202 Question Clinical Classification Standardized Character Response


name: CDISC Questionnaire Kidney Disease and Quality of Life-36 Version 1 Test Name Terminology


name: CDISC Questionnaire Kidney Disease and Quality of Life-36 Version 1 Test Code Terminology


name: CDISC Questionnaire Falls Efficacy Scale Test Name Terminology


name: CDISC Questionnaire Falls Efficacy Scale Test Code Terminology


name: CDISC ADaM National Early Warning Score 2 Clinical Classification Parameter Name Terminology


name: CDISC ADaM National Early Warning Score 2 Clinical Classification Parameter Code Terminology


name: Kidney Disease and Quality of Life-36 Version 1 Questionnaire Question


name: Falls Efficacy Scale Questionnaire Question


name: National Early Warning Score 2 Clinical Classification Question


name: Tanner Scale Girl TANN0101 Original Result - Stage 1


name: Tanner Scale Girl TANN0101 Original Result - Stage 2


name: Tanner Scale Girl TANN0101 Original Result - Stage 3


name: Tanner Scale Girl TANN0101 Original Result - Stage 4


name: Tanner Scale Girl TANN0101 Original Result - Stage 5


name: Tanner Scale Girl TANN0101 Standardized Character Result Stage 1


name: Tanner Scale Girl TANN0101 Standardized Character Result Stage 2


name: Tanner Scale Girl TANN0101 Standardized Character Result Stage 3


name: Tanner Scale Girl TANN0101 Standardized Character Result Stage 4


name: Tanner Scale Girl TANN0101 Standardized Character Result Stage 5


name: Tanner Scale Girl TANN0102 Original Result - Stage 1


name: Tanner Scale Girl TANN0102 Original Result - Stage 2


name: Tanner Scale Girl TANN0102 Original Result - Stage 3


name: Tanner Scale Girl TANN0102 Original Result - Stage 4


name: Tanner Scale Girl TANN0102 Original Result - Stage 5


name: Tanner Scale Girl TANN0102 Standardized Character Result Stage 1


name: Tanner Scale Girl TANN0102 Standardized Character Result Stage 2


name: Tanner Scale Girl TANN0102 Standardized Character Result Stage 3


name: Tanner Scale Girl TANN0102 Standardized Character Result Stage 4


name: Tanner Scale Girl TANN0102 Standardized Character Result Stage 5


name: Tanner Scale Boy TANN0201 Original Result - Stage 1


name: Tanner Scale Boy TANN0201 Original Result - Stage 2


name: Tanner Scale Boy TANN0201 Original Result - Stage 3


name: Tanner Scale Boy TANN0201 Original Result - Stage 4


name: Tanner Scale Boy TANN0201 Original Result - Stage 5


name: Tanner Scale Boy TANN0201 Standardized Character Result Stage 1


name: Tanner Scale Boy TANN0201 Standardized Character Result Stage 2


name: Tanner Scale Boy TANN0201 Standardized Character Result Stage 3


name: Tanner Scale Boy TANN0201 Standardized Character Result Stage 4


name: Tanner Scale Boy TANN0201 Standardized Character Result Stage 5


name: Tanner Scale Boy TANN0202 Original Result - Stage 1


name: Tanner Scale Boy TANN0202 Original Result - Stage 2


name: Tanner Scale Boy TANN0202 Original Result - Stage 3


name: Tanner Scale Boy TANN0202 Original Result - Stage 4


name: Tanner Scale Boy TANN0202 Original Result - Stage 5


name: Tanner Scale Boy TANN0202 Standardized Character Result Stage 1


name: Tanner Scale Boy TANN0202 Standardized Character Result Stage 2


name: Tanner Scale Boy TANN0202 Standardized Character Result Stage 3


name: Tanner Scale Boy TANN0202 Standardized Character Result Stage 4


name: Tanner Scale Boy TANN0202 Standardized Character Result Stage 5


name: Kidney Disease and Quality of Life-36 Version 1 Questionnaire


name: KDQOL-36 Version 1 - In General You Say Your Health Is


name: KDQOL-36 Version 1 - Limit Moderate Activities


name: KDQOL-36 Version 1 - Limit Climbing Several Flights


name: KDQOL-36 Version 1 - Physical: Accomplished Less


name: KDQOL-36 Version 1 - Physical: Limited Kind of Work


name: KDQOL-36 Version 1 - Emotional: Accomplished Less


name: KDQOL-36 Version 1 - Emotional: Did Work Less Carefully


name: KDQOL-36 Version 1 - Pain Interfere With Normal Work


name: KDQOL-36 Version 1 - Have You Felt Calm and Peaceful


name: KDQOL-36 Version 1 - Did You Have a Lot of Energy


name: KDQOL-36 Version 1 - You Felt Downhearted and Blue


name: KDQOL-36 Version 1 - Time Physical or Emotional Interfered


name: KDQOL-36 Version 1 - Kidney Disease Interferes With Life


name: KDQOL-36 Version 1 - Time Spent Deal With Kidney Disease


name: KDQOL-36 Version 1 - Frustrated Deal With Kidney Disease


name: KDQOL-36 Version 1 - I Feel Like a Burden on My Family


name: KDQOL-36 Version 1 - Bothered by Soreness in Muscles


name: KDQOL-36 Version 1 - Bothered by Chest Pain


name: KDQOL-36 Version 1 - Bothered by Itchy Skin


name: KDQOL-36 Version 1 - Bothered by Dry Skin


name: KDQOL-36 Version 1 - Bothered by Shortness of Breath


name: KDQOL-36 Version 1 - Bothered by Faintness or Dizziness


name: KDQOL-36 Version 1 - Bothered by Lack of Appetite


name: KDQOL-36 Version 1 - Bothered by Washed Out or Drained


name: KDQOL-36 Version 1 - Bothered by Numbness in Hands or Feet


name: KDQOL-36 Version 1 - Bothered by Nausea or Upset Stomach


name: KDQOL-36 Version 1 - Bothered by Problems With Access Site


name: KDQOL-36 Version 1 - Bothered by Problems Catheter Site


name: KDQOL-36 Version 1 - Bother Fluid Restriction


name: KDQOL-36 Version 1 - Bother Dietary Restriction


name: KDQOL-36 Version 1 - Bother Ability to Work Around House


name: KDQOL-36 Version 1 - Bother Your Ability to Travel


name: KDQOL-36 Version 1 - Bother Dependent on Doctors and Staff


name: KDQOL-36 Version 1 - Bother Stress Caused by Disease


name: KDQOL-36 Version 1 - Bother Your Sex Life


name: KDQOL-36 Version 1 - Bother Your Personal Appearance


name: FES - Prepare Meals Not Carrying Objects


name: National Early Warning Score 2 - Total Score for Analysis


name: National Early Warning Score 2 - Trigger for Analysis


name: Prophylactic Removal due to Corrective Action


name: Undesirable Presence of Endogenous Materials


name: Use of Non-Validated Controls Identified


name: Malfunction Observed Without Conclusive Finding


name: Cancer Antigen 125 [Units/Volume] in Serum or Plasma


name: CD30 Antigen [Presence] in Tissue by Immune Stain


name: CD20 Antigen [Presence] in Tissue by Immune Stain


name: Prostate-Specific Antigen [Presence] in Tissue by Immune Stain


name: Carcinoembryonic Antigen [Units/Volume] in Semen


name: Cancer Antigen 125 [Units/Volume] in Body Fluid


name: Carcinoembryonic Antigen [Mass/Volume] in Body Fluid


name: Cancer Antigen DM/70K [Units/Volume] in Serum or Plasma


name: Choriogonadotropin Beta Subunit [Units/Volume] in Cerebral Spinal Fluid


name: Cells with Estrogen Receptor/100 Cells in Tissue by Immune Stain


name: Cells with Progesterone Receptor/100 Cells in Tissue by Immune Stain


name: CD20 Abnormal Blood Cells/Abnormal Blood Cells Total in Blood


name: CD33 Abnormal Blood Cells/Abnormal Blood Cells Total in Blood


name: Gamma-Enolase [Mass/Volume] in Serum or Plasma


name: Cancer Antigen 125 [Units/Volume] in Body Fluid by Dilution


name: Cancer Antigen 125 [Units/Volume] in Serum or Plasma by Dilution


name: Cancer Antigen 27-29 [Units/Volume] in Serum or Plasma


name: Cancer Antigen 72-4 [Units/Volume] in Serum or Plasma


name: Cancer Antigen 19-9 [Units/Volume] in Pleural Fluid


name: Cancer Antigen 72-4 [Units/Volume] in Pleural Fluid


name: Cancer Antigen 125 [Units/Volume] in Pleural Fluid


name: Carcinoembryonic Antigen [Units/Volume] in Serum or Plasma


name: Carcinoembryonic Antigen [Moles/Volume] in Serum or Plasma


name: Carcinoembryonic Antigen [Units/Volume] in Pleural Fluid


name: Carcinoembryonic Antigen [Mass/Volume] in Pleural Fluid


name: Carcinoembryonic Antigen [Moles/Volume] in Pleural Fluid


name: Choriogonadotropin Beta Subunit [Units/Volume] in Amniotic Fluid


name: Choriogonadotropin Beta Subunit [Moles/Volume] in Amniotic Fluid


name: Cancer Antigen 27-29 [Units/Volume] in Pleural Fluid


name: Cancer Antigen 549 [Units/Volume] in Serum or Plasma


name: Cancer Antigen 549 [Units/Volume] in Pleural Fluid


name: Gamma-Enolase [Units/Volume] in Serum or Plasma


name: Gamma-Enolase [Units/Volume] in Pleural Fluid


name: Prostate-Specific Antigen [Units/Volume] in Serum or Plasma


name: Prostate-Specific Antigen [Moles/Volume] in Serum or Plasma


name: Prostate-Specific Antigen [Units/Volume] in Semen


name: Prostate-Specific Antigen [Mass/Volume] in Semen


name: Prostate-Specific Antigen [Moles/Volume] in Semen


name: Cancer Antigen 125 [Presence] in Serum or Plasma


name: Cancer Antigen 15-3 [Presence] in Serum or Plasma


name: Cancer Antigen 19-9 [Presence] in Serum or Plasma


name: Cancer Antigen 242 [Presence] in Serum or Plasma


name: Cancer Antigen 27-29 [Presence] in Serum or Plasma


name: Cancer Antigen 50 [Presence] in Serum or Plasma


name: Cancer Antigen 549 [Presence] in Serum or Plasma


name: Cancer Antigen 72-4 [Presence] in Serum or Plasma


name: Carcinoembryonic Antigen [Mass/Volume] in Cerebral Spinal Fluid


name: Carcinoembryonic Antigen [Mass/Volume] in Semen


name: Carcinoembryonic Antigen [Mass/Volume] in Serum or Plasma


name: Choriogonadotropin Beta Subunit [Units/Volume] in Serum or Plasma by Enzyme Immunoassay Third International Standard


name: CD20 Cells/100 Cells in Unspecified Specimen


name: CD22 Cells/100 Cells in Unspecified Specimen


name: CD33 Cells/100 Cells in Unspecified Specimen


name: Choriogonadotropin Beta Subunit [Moles/Volume] in Serum or Plasma


name: Choriogonadotropin Beta Subunit [Mass/Time] in 24 Hour Urine


name: Choriogonadotropin Beta Subunit [Moles/Volume] in Urine


name: Choriogonadotropin Beta Subunit [Units/Volume] in Serum or Plasma


name: BRCA1 Gene Variants Found [Identifier] in Blood or Tissue by Molecular Genetics Method Nominal


name: BRCA1 NM_007294.3:c.68_69delAG [Presence] in Blood or Tissue by Molecular Genetics Method


name: BRCA1 NM_007294.3c.5266dupC [Presence] in Blood or Tissue by Molecular Genetics Method


name: BRCA1 Gene Variants Tested for in Blood or Tissue by Molecular Genetics Method Nominal


name: BRCA2 NM_000059.3:c.5946delT [Presence] in Blood or Tissue by Molecular Genetics Method


name: KRAS Gene Variants Found [Identifier] in Blood or Tissue by Molecular Genetics Method Nominal


name: KRAS Gene Variants Tested for in Blood or Tissue by Molecular Genetics Method Nominal


name: Gamma-Enolase [Enzymatic Activity/Volume] in Serum or Plasma


name: Cancer Antigen 19-9 [Units/Volume] in Serum or Plasma


name: Cancer Antigen 19-9 [Units/Volume] in Body Fluid


name: Bladder Tumor Antigen [Presence] in Urine by Immunoassay


name: Bladder Tumor Antigen [Units/Volume] in Urine by Immunoassay


name: Prostate-Specific Antigen [Mass/Volume] in Serum or Plasma


name: Cancer Antigen 15-3 [Units/Volume] in Body Fluid


name: Choriogonadotropin Beta Subunit [Units/Volume] in Body Fluid


name: CD25 Antigen [Presence] in Tissue by Immune Stain


name: Nuclear Mitotic Apparatus Protein 1 [Units/Volume] in Urine


name: Bladder Tumor Antigen [Presence] in Urine


name: Bladder Tumor Antigen [Units/Volume] in Urine


name: Epidermal Growth Factor Receptor [Presence] in Tissue by Immune Stain


name: Receptor Tyrosine-Protein Kinase erbB-2 [Mass/Volume] in Serum


name: Cancer Antigen 72-4 [Units/Volume] in Body Fluid


name: Cancer Antigen 50 [Units/Volume] in Serum or Plasma


name: Des-Gamma Carboxyprothrombin [Mass/Volume] in Serum or Plasma


name: Prostate-Specific Antigen [Mass/Volume] in Urine


name: Prostate-Specific Antigen [Mass/Volume] in Serum or Plasma by Detection Limit Less than or Equal to 0.01 ng/ml


name: BRCA2 Gene Variants Found [Identifier] in Blood or Tissue by Molecular Genetics Method Nominal


name: BRCA2 Gene Variants Tested for in Blood or Tissue by Molecular Genetics Method Nominal


name: Epidermal Growth Factor Receptor [Presence] in Tissue


name: Mast/Stem Cell Growth Factor Receptor Kit [Presence] in Tissue by Immune Stain


name: Estrogen Receptor [Presence] in Tissue by Immune Stain


name: Progesterone Receptor [Presence] in Tissue by Immune Stain


name: Cancer Antigen 125 [Units/Volume] in Peritoneal Fluid


name: Carcinoembryonic Antigen [Mass/Volume] in Pericardial Fluid


name: Carcinoembryonic Antigen [Mass/Volume] in Peritoneal Fluid


name: Soluble Mesothelin Related Protein [Moles/Volume] in Serum or Plasma


name: Phosphorylated Epidermal Growth Factor Receptor [Presence] in Tissue by Immune Stain


name: Receptor Tyrosine-Protein Kinase erbB-2 [Mass/Volume] in Serum by Immunoassay


name: JAK2 NP_004963.1:p.V617F [Presence] in Blood or Tissue by Molecular Genetics Method


name: Choriogonadotropin Beta Subunit [Presence] in Specimen


name: Choriogonadotropin Beta Subunit [Presence] in Cerebral Spinal Fluid


name: Gamma-Enolase [Mass/Volume] in Cerebral Spinal Fluid


name: DPYD Gene Variants Found [Identifier] in Blood or Tissue by Molecular Genetics Method Nominal


name: Cancer Antigen 72-4 [Presence] in Tissue by Immune Stain


name: Gamma-Enolase [Mass/Volume] in Cerebral Spinal Fluid by Immunoassay


name: Prostate-Specific Antigen [Mass/Volume] in Body Fluid


name: Gamma-Enolase [Mass/Volume] in Serum or Plasma by Radioimmunoassay


name: Gamma-Enolase [Mass/Volume] in Body Fluid


name: Receptor Tyrosine-Protein Kinase erbB-2 [Interpretation] in Tissue


name: Cancer Antigen 125 [Presence] in Tissue by Immune Stain


name: X and Y Chromosome [Interpretation] in Blood or Marrow by FISH-Post Bone Marrow Transplant


name: X-Linked Heterotaxy [Identifier] in Blood or Tissue by FISH Narrative


name: FGFR2 Gene and FGFR3 Gene Variants Found [Identifier] in Blood or Tissue by Molecular Genetics Method Nominal


name: BCR/ABL1 b2a2 Type Fusion Protein [Presence] in Blood or Tissue by Molecular Genetics Method


name: Chromosome Analysis Interphase [Interpretation] in Bone Marrow by FISH Narrative


name: Nuclear Mitotic Apparatus Protein 1 [Presence] in Urine


name: Chromosome Analysis Interphase [Interpretation] in Blood by FISH Narrative


name: Cancer Antigen 125 [Units/Volume] in Cerebral Spinal Fluid


name: Cancer Antigen 15-3 [Units/Volume] in Cerebral Spinal Fluid


name: Cancer Antigen 15-3 [Units/Volume] in Pericardial Fluid


name: Cancer Antigen 15-3 [Units/Volume] in Peritoneal Fluid


name: Cancer Antigen 19-9 [Units/Volume] in Cerebral Spinal Fluid


name: Cancer Antigen 19-9 [Units/Volume] in Pericardial Fluid


name: Cancer Antigen 19-9 [Units/Volume] in Peritoneal Fluid


name: Cancer Antigen 27-29 [Units/Volume] in Cerebral Spinal Fluid


name: CD20 Blasts/100 Blasts in Unspecified Specimen


name: CD22 Blasts/100 Blasts in Unspecified Specimen


name: CD22 Blasts [Units/Volume] in Unspecified Specimen


name: CD33 Blasts/100 Blasts in Unspecified Specimen


name: CD33 Blasts [Units/Volume] in Unspecified Specimen


name: Mast/Stem Cell Growth Factor Receptor Kit [Presence] in Bone Marrow by Immune Stain


name: Mast/Stem Cell Growth Factor Receptor Kit [Presence] in Blood by Immune Stain


name: Mast/Stem Cell Growth Factor Receptor Kit [Presence] in Unspecified Specimen by Immune Stain


name: t(9;22)(q34.1;q11)(ABL1/BCR) Fusion Transcript in Blood or Tissue by FISH


name: Receptor Tyrosine-Protein Kinase erbB-2 [Presence] in Serum by Immunoassay


name: KRAS Gene Variants Found [Identifier] in Bone Marrow by Molecular Genetics Method Nominal


name: WAP Four-Disulfide Core Domain Protein 2 [Moles/Volume] in Serum or Plasma


name: Chromosome Analysis Interphase [Interpretation] in Amniotic Fluid by FISH Narrative


name: Chromosome Analysis Interphase [Interpretation] in Chorionic Villus Sample by FISH Narrative


name: Choriogonadotropin Beta Subunit [Multiple of the Median] in Serum or Plasma


name: Choriogonadotropin Beta Subunit [Mass/Volume] in Serum or Plasma


name: Choriogonadotropin Beta Subunit [Units] in 24 Hour Urine


name: Beta-2-Microglobulin Tumor Marker [Mass/Volume] in Serum